A new study in the New England Journal of Medicine highlights how some older Americans diagnosed with cancer can face unlimited out-of-pocket spending for prescription drugs under the current structure of the Medicare Part D benefit. The analysis, authored by Stacie Dusetzina, PhD, Ingram associate professor of Cancer Research and associate professor of Health Policy, […]
Major Players Daniel Beauchamp, MD, the John Clinton Foshee Distinguished Professor of Surgery, and Ethan Lee, MD, PhD, professor of Cell & Developmental Biology and Pharmacology: high-throughput screening to identify drug-like molecules, targeting the TGF-beta and WNT pathways Jordan Berlin, MD, co-director of the GI SPORE, interim director of the Division of Hematology and Oncology, […]
Abby Shields is the program manager for Affiliations and Research Advocacy at Vanderbilt-Ingram Cancer Center. Q: What do research advocates do? A: Our advocates are a group of cancer survivors and caregivers who work alongside our researchers to ensure the research conducted at VICC is timely, relevant and serves the needs of our catchment area. […]
Katie Lang, MS, CGC, is the director of Cancer Genetic Counseling Services and the medical director of Genetic Medicine at Vanderbilt University Medical Center. Q Who should undergo genetic testing for cancer risk? A Our understanding of genetics and cancer is rapidly evolving, so this question can be tricky. But, generally speaking, we know that […]
World Trade Center responders at higher risk for blood cancer-associated mutations Scientists from Vanderbilt-Ingram Cancer Center (VICC) collaborated with researchers from New York to determine that 9/11 first responders to the World Trade Center have increased levels of mutations that escalate their risk for blood cancers or cardiovascular disease, according to a study published March […]
A team of Vanderbilt researchers has revealed some of the mechanisms by which polyps develop into colorectal cancer, setting the framework for improved surveillance for the cancer utilizing precision medicine. Their study, published Dec. 14, 2021, in Cell, describes findings from a single-cell transcriptomic and imaging atlas of the two most common colorectal polyps found […]
Researchers at Vanderbilt University Medical Center and the University of Miami Miller School of Medicine have identified a subtype of triple-negative breast cancer (TNBC) that appears to be able to escape detection by the immune system and evade immunotherapy. Their report, published Nov. 1, 2021, in the journal Nature Communications, provides further evidence that TNBC […]
It has been my distinct honor to serve as the director of the Vanderbilt-Ingram Cancer Center for the past 15 years. I recently announced that I am stepping down on June 30 to serve as the chief scientific and strategy officer for Vanderbilt University Medical Center and will continue to serve as Executive VUMC Vice […]
We’re unlikely as patients to ever meet a pathologist, those doctors who, having examined samples of our blood or tissue, write reports and speak with our attending physicians about what’s fundamentally going on with our cases. When it comes to cancer treatment, how involved are these doctors? Take it from an oncologist: “The role of […]
When Ryan Merrell, MD, was in his third year of medical school at the University of Alabama, he hadn’t quite decided what specialty he would choose. Then life dealt a heavy blow, nudging him toward the field of neuro-oncology. His father, Jim, who had recently retired from Boeing in Huntsville, Alabama, was diagnosed with glioblastoma […]
